Orthocell Ltd News

Orthocell Fortifies Cash Position for US Expansion With A$3.05 Million R&D Tax Refund

Leading regenerative medicine company Orthocell Ltd (ASX:OCC, OTC:ORHHF) has secured an Australian Research and Development (R&D) Tax Incentive refund amounting to A$3.05 million for the fiscal year 2022-2023.

Investing.com Apr 14 21:54 ET

Orthocell Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 3%

Orthocell (ASX:OCC) secured a AU$3 million rebate from the Australian government's research and development tax incentive scheme, according to a Monday filing with the Australian Securities Exchange.

MT NewswiresApr 14 21:31 ET

Orthocell Revenue Soars 19% to AU$1.61 Million in Q1

Orthocell (ASX:OCC) posted its quarterly report for the period ended March 31 showing revenue rose 19% to AU$1.61 million compared with a year earlier, according to a Tuesday Australian bourse filing.

MT NewswiresApr 8 22:27 ET

Orthocell Ltd Reports Solid Revenue Growth

TipRanksApr 7 20:48 ET

Orthocell Moves Closer to US Market Clearance and Sales | ASX:OCC, OTC:ORHHF

Proactive InvestorsMar 26 08:50 ET

Orthocell Completes First Stage of Remplir US Market Authorization Study

Orthocell (ASX:OCC) has completed the first stage of its Remplir US market authorization study, allowing the regenerative medicine company to move forward with the remaining two stages, according to a

MT NewswiresMar 24 19:23 ET

Orthocell Secures A$3.5 Million in Strategic Placement to Fund Global Expansion and US Product Registration

Regenerative medicine company Orthocell Ltd (ASX:OCC, OTC:ORHHF) has secured firm commitments for a strategic placement amounting to A$3.5 million at A$0.37 per share.

Investing.com Feb 21 18:43 ET

Orthocell Submits Regulatory Application for Remplir in Singapore

Regenerative medicine company Orthocell (ASX:OCC) said its application to market and sell its peripheral nerve repair product Remplir in Singapore has been accepted by the Health Services Authority of

MT NewswiresFeb 12 21:05 ET

Orthocell Board Renewal to Focus on Balance Sheet and Commercialisation

Following its appointment of former Deputy Prime Minister Kim Beazley and as part of its board renewal, Orthocell Ltd (ASX:OCC, OTC:ORHHF) will say goodbye to board member Matthew Callahan, who was instrumental in the company’s early success.

Investing.com Jan 15 17:18 ET

Orthocell Initiated at Speculative Buy by Euroz Hartleys

Orthocell Initiated at Speculative Buy by Euroz Hartleys

Dow JonesDec 13, 2023 23:35 ET

The Five-year Returns Have Been for Orthocell (ASX:OCC) Shareholders Despite Underlying Losses Increasing

Yahoo FinanceJul 18, 2023 17:32 ET

Orthocell (ASX:OCC) Launches Fresh Rat Nerve-repair Study

The Market HeraldApr 17, 2023 21:46 ET

Orthocell (ASX:OCC) Bolsters Medical Scientific Advisory Board With US-based Nerve Surgeons

The Market HeraldMar 28, 2023 22:06 ET

Proactive News Headlines Including Orion Minerals, Lithium Australia, Orthocell Ltd and Strickland Metals

Sydney, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Orion Minerals Ltd (A

Yahoo FinanceSep 7, 2022 02:23 ET

Proactive news headlines including Orthocell Ltd, Antilles Gold, Buru Energy and Predictive Discovery

Sydney, June 07, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Orthocell Ltd (ASX:OCC

Yahoo FinanceJun 7, 2022 02:23 ET

Proactive news headlines including Orthocell Ltd, Alice Queen, RPM Automotive Group and Kazia Therapeutics

Sydney, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Orthocell Ltd (ASX:OCC

Yahoo FinanceFeb 24, 2022 02:24 ET